newsfilter
← Latest News
Business Wire·

Oragenics Q3 2025 Shareholder Update

Building on Solid Ground: From Vision to Execution Restoring Compliance, Advancing Innovation, Preparing for Clinical Milestones Oragenics, Inc. (NYSE:OGEN), a clinical-stage biotechnology company developing